Neovasc Inc. Reports Financial Results for 2012 Year-End

Published: Apr 29, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, April 29, 2013 /CNW/ - Neovasc Inc. ("Neovasc") (TSXV: NVC), today announced financial results for the year ended December 31, 2012. "In 2012 we made substantial progress in every area of our business," said Alexei Marko, CEO of Neovasc. "We continued our robust revenue growth, achieving good sales gains in all three of our businesses. This is the fourth consecutive year that we have achieved an average revenue growth of over 50% in our biological tissue and contract heart valve manufacturing division, as our marketing partner LeMaitre Vascular increased its sales and the cardiac device programs of our industry customers continued to advance towards commercialization.

Help employers find you! Check out all the jobs and post your resume.

Back to news